Treatment Decision-Making in Metastatic Prostate Cancer: Perceptions of Locus of Control Among Patient, Caregiver, and Physician Triads

被引:11
|
作者
Schumacher, Frank A. [1 ]
Helenowski, Irene B. [1 ]
Oswald, Laura B. [2 ]
Gonzalez, Brian D. [2 ]
Benning, James T. [1 ]
Morgans, Alicia K. [1 ]
机构
[1] Northwestern Univ, Feinberg Sch Med, 1835 W Thomas St,Apt 2F, Chicago, IL 60622 USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Program Hlth Outcomes & Behav, Tampa, FL USA
来源
PATIENT PREFERENCE AND ADHERENCE | 2022年 / 16卷
关键词
prostate cancer; decision making; shared decision making; treatment decisions; cancer; INVOLVEMENT; PREFERENCES; INFORMATION; ROLES; WOMEN;
D O I
10.2147/PPA.S334827
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Multiple treatments for metastatic prostate cancer have similar efficacy, leaving patients with complicated treatment choices. Shared decision-making can facilitate difficult treatment decisions, but the extent to which this is used for metastatic prostate cancer is unknown. We assessed patient, caregiver, and physician perceptions of decision locus of control (shared decision-making vs physician- or patient-directed decisions) and the degree of agreement between groups. Methods: Triads of patients, caregivers, and physicians completed surveys of decisionmaking practices after a clinic visit in which a decision occurred. To evaluate the degree of agreement for decision locus of control, we used the quadratic-weighted kappa coefficient (Kappa). We used relative frequencies to evaluate which knowledge learned and treatment factors were most strongly endorsed by patients as informing and influencing their treatment decision-making, respectively. Results: Fifty triads participated, with median patient age of 72 years. A majority of patients, caregivers, and physicians reported shared decision-making (66%, 56%, and 52%, respectively). Patients and physicians demonstrated minimal agreement about decision locus of control (44%, Kappa=0.35 [SD = 0.52]), but caregiver reports were not statistically significantly associated with physician and patient reports (38%, Kappa=0.23, [SD = 0.28]), p=0.055; 44%, Kappa=0.34 [SD = 1.98], p=0.14). Treatment efficacy was the most common patientreported factor influencing treatment decisions (44%). Conclusion: This study characterized metastatic prostate cancer patients', caregivers', and physicians' experiences and communication preferences for treatment decision-making. Patients and physicians had greater agreement in decision locus of control compared with caregivers, yet patient-physician agreement was minimal. Metastatic prostate cancer patients report being influenced by information about treatment efficacy and clear next steps, and a desire for patient-friendly language and an invitation to be as involved in decision making at their preferred level. Emphasizing these may increase agreement in decision locus of control between all participants in the decision-making process.
引用
收藏
页码:235 / 244
页数:10
相关论文
共 50 条
  • [31] EXPECTATIONS ABOUT CURE, PHYSICIAN-PATIENT COMMUNICATION, AND TREATMENT DECISION-MAKING IN CANCER PATIENTS
    Harper, Felicity
    Gleason, Marci
    Eggly, Susan
    Ruckdeschel, John
    Albrecht, Terrance
    ANNALS OF BEHAVIORAL MEDICINE, 2007, 33 : S97 - S97
  • [32] Patient Decision-Making Factors in Aggressive Treatment of Low-Risk Prostate Cancer
    Basak, Ramsankar
    Usinger, Deborah S.
    Chen, Ronald C.
    Shen, Xinglei
    JNCI CANCER SPECTRUM, 2022, 6 (01)
  • [33] Preferences for and experiences of family involvement in cancer treatment decision-making: patient-caregiver dyads study
    Shin, Dong Wook
    Cho, Juhee
    Roter, Debra L.
    Kim, So Young
    Sohn, Sang Kyun
    Yoon, Man-Soo
    Kim, Young-Woo
    Cho, BeLong
    Park, Jong-Hyock
    PSYCHO-ONCOLOGY, 2013, 22 (11) : 2624 - 2631
  • [34] Health care team and treatment decision-making experiences among prostate cancer patients
    Nicksic, Nicole E.
    Miller, Melissa F.
    Clark, Kelly
    Zaleta, Alexandra Katherine
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [35] Patient Activation and Shared Decision-Making Among Hispanics/Latinos With Metastatic Cancer: A Qualitative Study
    Meguro, Julia
    Khawand-Azoulai, Mariana
    Medina, Heidy N.
    Pons, Magela
    Huber, Michael T.
    Penedo, Frank J.
    Moreno, Patricia I.
    PSYCHO-ONCOLOGY, 2025, 34 (04)
  • [36] Method of Presenting Oncology Treatment Outcomes Influences Patient Treatment Decision-Making in Metastatic Colorectal Cancer
    Robert C. G. Martin
    Sheri A. McGuffin
    Lynne M. Roetzer
    Troy D. Abell
    Jamie L. Studts
    Annals of Surgical Oncology, 2006, 13 : 86 - 95
  • [37] Method of presenting oncology treatment outcomes influences patient treatment decision-making in metastatic colorectal cancer
    Martin, RCG
    McGuffin, SA
    Roetzer, LM
    Abell, TD
    Studts, JL
    ANNALS OF SURGICAL ONCOLOGY, 2006, 13 (01) : 86 - 95
  • [38] Patient Perceptions of Illness Identity in Cancer Clinical Trial Decision-Making
    Palmer-Wackerly, Angela L.
    Dailey, Phokeng M.
    Krok-Schoen, Jessica L.
    Rhodes, Nancy D.
    Krieger, Janice L.
    HEALTH COMMUNICATION, 2018, 33 (08) : 1045 - 1054
  • [39] Prostate cancer decision-making: a national survey on treatment and research
    Osian, Sarah
    Monticalvo, David
    Mendenhall, Nancy
    Hoppe, Bradford
    Bradley, Julie
    PSYCHO-ONCOLOGY, 2015, 24 : 43 - 44
  • [40] Treatment decision-making in early-stage prostate cancer
    Denberg, TD
    Melhado, TV
    Kim, JF
    Steiner, JF
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2005, 20 : 194 - 194